Exact Mass: 408.0644

Chloroatranorin

C19H17ClO8 (408.0612)

trans-6-Debromo-3,4-dihydrohamacanthin

C20H17BrN4O (408.0586)

Bazzania acid

C18H16O11 (408.0693)

cis-6-Debromo-3,4-dihydrohamacanthin

C20H17BrN4O (408.0586)

Metrafenone

C19H21BrO5 (408.0572)

CONFIDENCE standard compound; EAWAG_UCHEM_ID 3063

C17H26BrClO4

C17H26BrClO4 (408.0703)

SCHEMBL17537654

C20H17BrN4O (408.0586)

3-(6-Bromo-1H-indole-3-yl)-6-(1H-indole-3-yl)piperazine-2-one

C20H17BrN4O (408.0586)

2-C-beta-D-xylopyranosyl-1,3,4,6,7-pentahydroxyxanthone|aquilarixanthone

C18H16O11 (408.0693)

herbamide B

C17H23Cl3N2OS (408.0597)

Antibiotic KA 6643D

C14H20N2O8S2 (408.0661)

Ser-Phe4Cl-OH

C18H17ClN2O7 (408.0724)

Phe4Cl-Thr-OH

C18H17ClN2O7 (408.0724)

Elfazepam

C19H18ClFN2O3S (408.0711)

C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

1-((2-(6-BROMOQUINOLIN-4-YL)-1-(PYRIDIN-2-YL)ETHYLIDENE)AMINO)PYRROLIDIN-2-ONE

C20H17BrN4O (408.0586)

Glafenine Hydrochloride

C19H18Cl2N2O4 (408.0644)

1-[2,6-DICHLORO-4-(FLUOROMETHYL)PHENYL]-3-(2-METHYLPROPYL)-1H-PYRAZOLE-5-CARBOXYLIC ACID ETHYL ESTER

C17H17Cl2F3N2O2 (408.0619)

Paraquat methosulfate

C14H20N2O8S2 (408.0661)

N-(4-Aminobenzenesulfonyl) Sulfamethoxazole

C16H16N4O5S2 (408.0562)

tert-Butyl-4-[3-bromo-5-(trifluoromethyl)-phenyl]-1-piperazine Carboxylate

C16H20BrF3N2O2 (408.066)

4-(2,3-Dichloro-phenyl)-2,6-dimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-(2-cyano-ethyl) ester 5-methyl ester

C19H18Cl2N2O4 (408.0644)

1-Methyl-1-propylpyrrolidinium bis(trifluoromethanesulfonyl)imide

C10H18F6N2O4S2 (408.0612)

(6E)-6-(3-ethoxy-4-hydroxybenzylidene)-2-(ethylsulfonyl)-5-imino-5,6-dihydro-7H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-7-one

C16H16N4O5S2 (408.0562)

2-[(5,6-dithiophen-2-yl-1,2,4-triazin-3-yl)oxy]-N-methyl-N-phenylacetamide

C20H16N4O2S2 (408.0715)

N-(1,3-benzodioxol-5-yl)-2-[2-(3-chloro-4-methylanilino)-2-oxoethyl]sulfinylacetamide

C18H17ClN2O5S (408.0547)

1,3,4,6,7-pentahydroxy-2-[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]xanthen-9-one

C18H16O11 (408.0693)

8,8,8-trichloro-2,7-dimethyl-n-[2-methyl-1-(1,3-thiazol-2-yl)propyl]octa-2,4-dienimidic acid

C17H23Cl3N2OS (408.0597)

Aquilarixanthone

C18H16O11 (408.0693)

{"Ingredient_id": "HBIN016545","Ingredient_name": "Aquilarixanthone","Alias": "NA","Ingredient_formula": "C18H16O11","Ingredient_Smile": "C1C(C(C(C(O1)C2=C(C(=C3C(=C2O)C(=O)C4=CC(=C(C=C4O3)O)O)O)O)O)O)O","Ingredient_weight": "408.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "33137","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "51034839","DrugBank_id": "NA"}

(3s,5s)-5-acetyl-5-[(1s,3s,4s)-3-bromo-4-chloro-4-methylcyclohexyl]-2,2-dimethyloxolan-3-yl acetate

C17H26BrClO4 (408.0703)

(1s,4z,5r,6r)-5-(carboxymethyl)-4-(carboxymethylidene)-6-(3,4-dihydroxyphenyl)-5-hydroxycyclohex-2-ene-1,2-dicarboxylic acid

C18H16O11 (408.0693)

(7s)-8,8,8-trichloro-2,7-dimethyl-n-[(1s)-2-methyl-1-(1,3-thiazol-2-yl)propyl]octa-2,4-dienimidic acid

C17H23Cl3N2OS (408.0597)

(2e,4e)-8,8,8-trichloro-2,7-dimethyl-n-[(1s)-2-methyl-1-(1,3-thiazol-2-yl)propyl]octa-2,4-dienimidic acid

C17H23Cl3N2OS (408.0597)

[(2r,3r,4s,5r,8e)-9-(3,4-dihydroxyphenyl)-1,2,3,5-tetrahydroxy-6-oxonon-8-en-4-yl]oxysulfonic acid

C15H20O11S (408.0726)

(2e,4e,7s)-8,8,8-trichloro-2,7-dimethyl-n-[(1s)-2-methyl-1-(1,3-thiazol-2-yl)propyl]octa-2,4-dienimidic acid

C17H23Cl3N2OS (408.0597)

5-acetyl-5-(3-bromo-4-chloro-4-methylcyclohexyl)-2,2-dimethyloxolan-3-yl acetate

C17H26BrClO4 (408.0703)

[(2r,3r,4s,5r,8e)-9-(3,4-dihydroxyphenyl)-2,3,4,5-tetrahydroxy-6-oxonon-8-en-1-yl]oxysulfonic acid

C15H20O11S (408.0726)